06/18/2021 | Press release | Distributed by Public on 06/19/2021 00:04
Jun 18, 2021
Origin: ASRM Press Release
This statement addresses 'Sperm parameters before and after COVID-19 mRNA vaccination', published in the Journal of the American Medical Association today.
'The news that the COVID-19 vaccine has no impact on sperm count should come as no surprise,' said Hugh Taylor, M.D, president of the American Society for Reproductive Medicine. 'The finding that mRNA vaccines - including the COVID-19 vaccine - do not negatively affect male reproductive potential is good news now, as well as good news for future coronavirus outbreaks. ASRM has long recommended that women and men get vaccinated no matter where they are on their family-building journey,' he added. 'And, for men age 30 and under - the most vaccine-resistant population in the U.S. - this is the second good reason for them to get the COVID-19 vaccine. One of the study's authors Dr. Ranjith Ramasamy's earlier work established that having COVID could increase the chances of men having erectile dysfunction.'
For more information on these press releases, contact:
J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494
ASRM Bulletins are published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at [email protected].
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
Ph: 202-863-2494 or 202-421-5112 (mobile)
Email: [email protected]